intuniv
takeda pharmaceuticals international ag ireland branch - гуанацин хидрохлорид - Нарушение на дефицита на вниманието с хиперактивност - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv трябва да се използва като част от цялостна програма за лечение на adhd, като цяло, включително и психологически, образователни и социални мерки.
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - Захарен диабет тип 2 - Лекарства, използвани при диабет - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 и 5. 1 за наличните данни за различни комбинации).
baneocin 5000iu /250iu /g ointment
sandoz gmbh - Неомицина, Бацитрацина - 5000iu /250iu /g ointment
dalacin c 75 mg/5 ml granules for syrup
pfizer enterprises sarl - Клиндамицин - 75 mg/5 ml granules for syrup
dalacin 2% vaginal cream
pfizer enterprises sarl - Клиндамицин - 2% vaginal cream
dalacin c 150 mg/ml solution for injection
pfizer enterprises sarl - Клиндамицин - 150 mg/ml solution for injection
dalacin c 150 mg hard capsules
pfizer enterprises sarl - Клиндамицин - 150 mg hard capsules
dalacin c 300 mg hard capsules
pfizer enterprises sarl - Клиндамицин - 300 mg hard capsules
dalacin t 10 mg/ml cutaneous solution
pfizer enterprises sarl - Клиндамицин - 10 mg/ml cutaneous solution
baneocin 250 iu/ 5000 iu/g cutaneous powder
250 iu/ 5000 iu/g cutaneous powder